S5237Referred to Committee
Stop Superbugs Act
Introduced
In Committee
3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2026-08-04
Introduced
1
Cosponsors
S
ⓘType
Sponsor
Margaret Wood Hassan
Democrat · NH · Senator
Votes with party: 75.0% (901 recorded votes)
Full profile: /officials/H001076
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-08-04
Source: Congress.gov
Committee Activity
Currently in
- Senate Committee on Health, Education, Labor, and PensionsReferred To · 2026-08-04
Plain-English Summary
Plain-English summary pending. Introduced on 2026-08-04. Check back soon — summaries are generated as bills progress through Congress.
Subjects
Health
Full Bill Text
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 5237 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 5237 To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES August 4, 2026 Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Stop Superbugs Act''. SEC. 2. FUNDING FOR ANTIBIOTIC RESISTANCE CLINICAL RESEARCH. (a) In General.--The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on-- (1) supporting rapid recruitment of clinical trial participants; (2) conducting clinical trial recruitment outreach in community settings; (3) supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and (4) developing patient-reported outcomes in clinical studies. (b) Authorization of Appropriations.--There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a). <all>
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S5671State Strategic Stockpile Act of 2026Referred to Committee · 2026-09-30
- SRES921A resolution expressing the sense of the Senate that the advertisements promoting President Donald Trump that aired in September 2026, which included the direct language "paid for by the U.S. Government," should not be paid for by the United States Government.Referred to Committee · 2026-09-29
- S5502Protecting Biotechnology and Biomanufacturing as Critical Infrastructure ActReferred to Committee · 2026-09-24
- S5516Keep Food Containers Safe from PFAS Act of 2026Referred to Committee · 2026-09-24